A reflection on the actual place of osimertinib in the treatment algorithm of EGFR-positive non-small cell lung cancer patients

J Thorac Dis. 2020 Oct;12(10):6107-6111. doi: 10.21037/jtd-20-1733.

Authors

Alessio Cortellini^{1

2}, Corrado Ficorella^{1

2}, Roberto Crisci³, Duilio Divisi³

Affiliations

¹ Medical Oncology Unit, San Salvatore Hospital, University of L'Aquila, L'Aquila, Italy.
² Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
³ Thoracic Surgery, University of L'Aquila, "G. Mazzini" Hospital of Teramo, Teramo, Italy.

No abstract available

Publication types

Editorial
Comment